9 recruiting. 9 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Recruiting 9 |
| Phase 2 | 2 | Recruiting 2 |
Follow Suppuration: new trials by email Literature Review of Suppuration trials Research Report on Suppuration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS LOU064, Placebo - Hidradenitis Suppurativa | Phase 1 | Recruiting | Novartis Pharmaceuticals | 30 | 2026-10-15 | 2026-10-16 |
| Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa Soquelitinib - Hidradenitis Suppurativa (HS) | Phase 1 | Recruiting | Corvus Pharmaceuticals, Inc. | 25 | 2026-09-17 | 2026-10-15 |
| Biological, Radiographic and Clinical Evaluation of Various Inter-Visit Root Canal Dressings in Retreatment Cases Calcium Silicate Intracanal Medication, Calcium Hydroxide Slurry mixed with Sodium Hypochlorite Intracanal Medication, Calcium Hydroxide (Ca(OH)2) Intracanal Medication - Intervention Studies, ASA Physical Status I | Phase 1 | Recruiting | Ain Shams University | 60 | 2026-06-01 | 2026-06-12 |
| A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) Bimekizumab - Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis | Phase 1 | Recruiting | UCB Biopharma SRL | 20 | 2025-11-05 | 2026-09-18 |
| Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa Ruxolitinib Cream - Hidradenitis Suppurativa | Phase 1 | Recruiting | Incyte Corporation | 24 | 2025-11-03 | 2026-10-09 |
| 1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa) AviClear Lase Treatment, Sham (No Treatment) - Hidradenitis Suppurativa (HS) | Phase 1 | Recruiting | Wynn Medical Center | 30 | 2025-09-15 | 2025-09-17 |
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa LT-002-158 Tablets - Hidradenitis Suppurativa (HS) | Phase 1 / Phase 2 | Recruiting | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 12 | 2025-07-08 | 2026-08-27 |
| A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients QLS12010, Placebo - Atopic Dermatitis, Hidradenitis Suppurativa (HS) | Phase 1 | Recruiting | Shanghai Qilu Pharmaceutical Research and Development Center LTD | 102 | 2025-03-31 | 2025-07-31 |
| Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. HB0043 - Hidradenitis Suppurativa | Phase 1 / Phase 2 | Recruiting | Shanghai Huaota Biopharmaceutical Co., Ltd. | 15 | 2025-03-19 | 2026-01-07 |
Hidradenitis Suppurativa (8) · Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Axial Spondyloarthritis (1) · Dermatitis, Atopic (1) · Periapical Abscess (1) · Skin Diseases (1)
Infections (9) · Bacterial Infections (8) · Bacterial Infections and Mycoses (8) · Hidradenitis (8) · Skin Diseases, Bacterial (8) · Skin Diseases, Infectious (8) · Skin and Connective Tissue Diseases (8) · Sweat Gland Diseases (8) · Skin Diseases (7) · Arthritis (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Abscess (1) · Ankylosis (1)
Calcium Hydroxide (1) · bimekizumab (1) · remibrutinib (1)
Ain Shams University (1) · Corvus Pharmaceuticals, Inc. (1) · Incyte Corporation (1) · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (1) · Novartis Pharmaceuticals (1) · Shanghai Huaota Biopharmaceutical Co., Ltd. (1) · Shanghai Qilu Pharmaceutical Research and Development Center LTD (1) · UCB Biopharma SRL (1) · Wynn Medical Center (1)
United States (5) · China (3) · Canada (1) · Egypt (1) · Germany (1) · Spain (1) · Switzerland (1)
2025 (1)